Vital 5 Gets FDA Approval for Dual-Function Catheter

Vital 5, LLC, a VentureMD portfolio company, has received clearance from the U. S. Food and Drug Administration for ReLeaf, a dual-function catheter system that provides simultaneous anesthetic infusion and wound drainage.

Continuous anesthetic infusion to the surgical site in the immediate post-operative period has been clinically proven to provide significant improvements to pain management, but this therapy is currently not compatible with the millions of surgical cases where a wound drain is prescribed. Vital 5 intends that, by offering an integrated system that provides effective continuous local anesthetic infusion while also providing an effective wound drain function, ReLeaf will expand the number of patients who can benefit from local anesthetic infusion therapy.

The clinical applications for the Vital 5 ReLeaf include any invasive surgical procedure, including spine, orthopedic, cardiothoracic, plastic, general, obstetrics and gynecological procedures.